CHICAGO, Jan. 30, 2019 /PRNewswire/ -- EVERSANA™, the leading independent provider of global services to the life science industry, today unveils Health Strategies Insights by EVERSANA, a comprehensive market access research and insights portfolio to help life science innovators make more informed decisions throughout the product lifecycle.
Originally developed by Health Strategies Group, a company that integrated into EVERSANA's life science services platform in 2018, Health Strategies Insights includes syndicated, custom, and access express research models to track global industry trends and inform specific client challenges.
"The evolution of our market intelligence capabilities strengthens EVERSANA's growing life science platform," said Rod Cavin, General Manager for Health Strategies Insights by EVERSANA. "The product portfolio provides valuable market access insights to leading global biopharmaceutical companies in various phases of product development across a number of therapeutic areas - helping our clients achieve commercial success."
Health Strategies Insights is backed by leading researchers, specializing in health plans, IDNs and ACOs. The team has access to an unrivaled expert network of payers and providers that include 23 of the top 25 health plans, 27,000 specialist physicians in the United States, and connectivity to a network of market access stakeholders in more than 14 countries around the world.
"Our platform will continually evolve to address never-ending complexities in the life science industry," said Jim Lang, CEO, EVERSANA. "Not only can we help clients achieve optimal market access through proven global research, we take those insights and help our clients navigate drug pricing, reimbursement, adherence, and product delivery challenges. It's the kind of partnership this industry needs."
EVERSANA™ is the leading independent provider of global services to the life science industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product lifecycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies to advance life science solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and Twitter.
About Health Strategies Insights by EVERSANA™
Health Strategies Insights by EVERSANA™ is a comprehensive market access research and insights portfolio to help life science innovators make more informed decisions throughout the product lifecycle. It tracks market place trends, and clients can utilize their tools to deploy custom research to global panels, or get a quick pulse on issues that matter to them in a few days. To learn more visit eversana.com.